PKMYT1 and non-small cell lung carcinoma: Consistent with former findings [14, 36], PKMYT1 is highly expressed and frequently mutated in multiple types of human cancers including NSCLC, which results in worse clinical outcome (Fig. 4d-g and Fig. S4a-c, Table S4-S5).